196 related articles for article (PubMed ID: 15252835)
41. Lack of HIN-1 methylation in BRCA1-linked and "BRCA1-like" breast tumors.
Krop I; Maguire P; Lahti-Domenici J; Lodeiro G; Richardson A; Johannsdottir HK; Nevanlinna H; Borg A; Gelman R; Barkardottir RB; Lindblom A; Polyak K
Cancer Res; 2003 May; 63(9):2024-7. PubMed ID: 12727813
[TBL] [Abstract][Full Text] [Related]
42. CpG methylation and transcription factors Sp1 and Sp3 regulate the expression of the human secretin receptor gene.
Pang RT; Lee LT; Ng SS; Yung WH; Chow BK
Mol Endocrinol; 2004 Feb; 18(2):471-83. PubMed ID: 14645499
[TBL] [Abstract][Full Text] [Related]
43. Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer.
Chan KY; Ozçelik H; Cheung AN; Ngan HY; Khoo US
Cancer Res; 2002 Jul; 62(14):4151-6. PubMed ID: 12124354
[TBL] [Abstract][Full Text] [Related]
44. Methylation-related mutations in the BRCA1 promoter in peripheral blood cells from cancer-free women.
Al-Moghrabi N; Al-Qasem AJ; Aboussekhra A
Int J Oncol; 2011 Jul; 39(1):129-35. PubMed ID: 21537840
[TBL] [Abstract][Full Text] [Related]
45. Silencing of caspase-8 in murine hepatocellular carcinomas is mediated via methylation of an essential promoter element.
Liedtke C; Zschemisch NH; Cohrs A; Roskams T; Borlak J; Manns MP; Trautwein C
Gastroenterology; 2005 Nov; 129(5):1602-15. PubMed ID: 16285959
[TBL] [Abstract][Full Text] [Related]
46. Correlation between the single-site CpG methylation and expression silencing of the XAF1 gene in human gastric and colon cancers.
Zou B; Chim CS; Zeng H; Leung SY; Yang Y; Tu SP; Lin MC; Wang J; He H; Jiang SH; Sun YW; Yu LF; Yuen ST; Kung HF; Wong BC
Gastroenterology; 2006 Dec; 131(6):1835-43. PubMed ID: 17087954
[TBL] [Abstract][Full Text] [Related]
47. Epigenetic repression of RARRES1 is mediated by methylation of a proximal promoter and a loss of CTCF binding.
Peng Z; Shen R; Li YW; Teng KY; Shapiro CL; Lin HJ
PLoS One; 2012; 7(5):e36891. PubMed ID: 22615834
[TBL] [Abstract][Full Text] [Related]
48. Levels of DNA Methylation Vary at CpG Sites across the BRCA1 Promoter, and Differ According to Triple Negative and "BRCA-Like" Status, in Both Blood and Tumour DNA.
Daniels SL; Burghel GJ; Chambers P; Al-Baba S; Connley DD; Brock IW; Cramp HE; Dotsenko O; Wilks O; Wyld L; Cross SS; Cox A
PLoS One; 2016; 11(7):e0160174. PubMed ID: 27463681
[TBL] [Abstract][Full Text] [Related]
49. Methylation profiles of the BRCA1 promoter in hereditary and sporadic breast cancer among Han Chinese.
Pang D; Zhao Y; Xue W; Shan M; Chen Y; Zhang Y; Zhang G; Liu F; Li D; Yang Y
Med Oncol; 2012 Sep; 29(3):1561-8. PubMed ID: 22076508
[TBL] [Abstract][Full Text] [Related]
50. BRCA1 expression status in relation to DNA methylation of the BRCA1 promoter region in sporadic breast cancers.
Niwa Y; Oyama T; Nakajima T
Jpn J Cancer Res; 2000 May; 91(5):519-26. PubMed ID: 10835497
[TBL] [Abstract][Full Text] [Related]
51. BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles.
Matros E; Wang ZC; Lodeiro G; Miron A; Iglehart JD; Richardson AL
Breast Cancer Res Treat; 2005 May; 91(2):179-86. PubMed ID: 15868446
[TBL] [Abstract][Full Text] [Related]
52. Association of BRCA1 promoter methylation with rs11655505 (c.2265C>T) variants and decreased gene expression in sporadic breast cancer.
Hasan TN; Leena Grace B; Shafi G; Syed R
Clin Transl Oncol; 2013 Jul; 15(7):555-62. PubMed ID: 23263908
[TBL] [Abstract][Full Text] [Related]
53. BRCA1 promoter methylation associated with poor survival in Chinese patients with sporadic breast cancer.
Chen Y; Zhou J; Xu Y; Li Z; Wen X; Yao L; Xie Y; Deng D
Cancer Sci; 2009 Sep; 100(9):1663-7. PubMed ID: 19522853
[TBL] [Abstract][Full Text] [Related]
54. Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.
Miyamoto K; Fukutomi T; Asada K; Wakazono K; Tsuda H; Asahara T; Sugimura T; Ushijima T
Jpn J Clin Oncol; 2002 Mar; 32(3):79-84. PubMed ID: 11956301
[TBL] [Abstract][Full Text] [Related]
55. Gain of DNA methylation is enhanced in the absence of CTCF at the human retinoblastoma gene promoter.
Dávalos-Salas M; Furlan-Magaril M; González-Buendía E; Valdes-Quezada C; Ayala-Ortega E; Recillas-Targa F
BMC Cancer; 2011 Jun; 11():232. PubMed ID: 21663659
[TBL] [Abstract][Full Text] [Related]
56. Mapping patterns of CpG island methylation in normal and neoplastic cells implicates both upstream and downstream regions in de novo methylation.
Graff JR; Herman JG; Myöhänen S; Baylin SB; Vertino PM
J Biol Chem; 1997 Aug; 272(35):22322-9. PubMed ID: 9268383
[TBL] [Abstract][Full Text] [Related]
57. CTCF negatively regulates HOXA10 expression in breast cancer cells.
Mustafa M; Lee JY; Kim MH
Biochem Biophys Res Commun; 2015 Nov; 467(4):828-34. PubMed ID: 26478432
[TBL] [Abstract][Full Text] [Related]
58. Association of BRCA1 promoter methylation with sporadic breast cancers: Evidence from 40 studies.
Zhang L; Long X
Sci Rep; 2015 Dec; 5():17869. PubMed ID: 26643130
[TBL] [Abstract][Full Text] [Related]
59. BRCA1 methylation: a significant role in tumour development?
Catteau A; Morris JR
Semin Cancer Biol; 2002 Oct; 12(5):359-371. PubMed ID: 12191635
[TBL] [Abstract][Full Text] [Related]
60. Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics.
Catteau A; Harris WH; Xu CF; Solomon E
Oncogene; 1999 Mar; 18(11):1957-65. PubMed ID: 10208417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]